106 related articles for article (PubMed ID: 12635015)
1. [Diffusion-weighted MRI--a new parameter for advanced rectal carcinoma?].
Hein PA; Kremser C; Judmaier W; Griebel J; Rudisch A; Pfeiffer KP; Hug EB; Lukas P; DeVries AF
Rofo; 2003 Mar; 175(3):381-6. PubMed ID: 12635015
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging.
Kremser C; Judmaier W; Hein P; Griebel J; Lukas P; de Vries A
Strahlenther Onkol; 2003 Sep; 179(9):641-9. PubMed ID: 14628131
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study.
Hein PA; Kremser C; Judmaier W; Griebel J; Pfeiffer KP; Kreczy A; Hug EB; Lukas P; DeVries AF
Eur J Radiol; 2003 Mar; 45(3):214-22. PubMed ID: 12595106
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?].
Liersch T; Langer C; Jakob C; Müller D; Ghadimi BM; Siemer A; Markus PM; Füzesi L; Becker H
Chirurg; 2003 Mar; 74(3):224-34. PubMed ID: 12647079
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.
Cai G; Xu Y; Zhu J; Gu WL; Zhang S; Ma XJ; Cai SJ; Zhang Z
World J Gastroenterol; 2013 Sep; 19(33):5520-7. PubMed ID: 24023496
[TBL] [Abstract][Full Text] [Related]
7. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging.
Blazic IM; Lilic GB; Gajic MM
Radiology; 2017 Feb; 282(2):418-428. PubMed ID: 27253423
[TBL] [Abstract][Full Text] [Related]
9. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
11. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
12. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.
Koh DM; Chau I; Tait D; Wotherspoon A; Cunningham D; Brown G
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):456-61. PubMed ID: 18164860
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging in suspected rectal cancer: determining tumor localization, stage, and sphincter-saving resectability at 3-Tesla-sustained high resolution.
Winter L; Bruhn H; Langrehr J; Neuhaus P; Felix R; Hänninen LE
Acta Radiol; 2007 May; 48(4):379-87. PubMed ID: 17453515
[TBL] [Abstract][Full Text] [Related]
14. Are ADC values of readout-segmented echo-planar diffusion-weighted imaging (RESOLVE) correlated with pathological prognostic factors in rectal adenocarcinoma?
Tang C; Lin MB; Xu JL; Zhang LH; Zuo XM; Zhang ZS; Liu MX; Xu JM
World J Surg Oncol; 2018 Jul; 16(1):138. PubMed ID: 30001205
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
[TBL] [Abstract][Full Text] [Related]
16. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
[TBL] [Abstract][Full Text] [Related]
17. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.
Sun YS; Zhang XP; Tang L; Ji JF; Gu J; Cai Y; Zhang XY
Radiology; 2010 Jan; 254(1):170-8. PubMed ID: 20019139
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study.
Genovesi D; Filippone A; Ausili Cèfaro G; Trignani M; Vinciguerra A; Augurio A; Di Tommaso M; Borzillo V; Sabatino F; Innocenti P; Liberatore E; Colecchia G; Tartaro A; Cotroneo AR
Eur J Surg Oncol; 2013 Oct; 39(10):1071-8. PubMed ID: 23953231
[TBL] [Abstract][Full Text] [Related]
19. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer.
Maretto I; Pomerri F; Pucciarelli S; Mescoli C; Belluco E; Burzi S; Rugge M; Muzzio PC; Nitti D
Ann Surg Oncol; 2007 Feb; 14(2):455-61. PubMed ID: 17139456
[TBL] [Abstract][Full Text] [Related]
20. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer.
Lambrecht M; Deroose C; Roels S; Vandecaveye V; Penninckx F; Sagaert X; van Cutsem E; de Keyzer F; Haustermans K
Acta Oncol; 2010 Oct; 49(7):956-63. PubMed ID: 20586658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
